ReI Tricarbonyl Complexes as Coordinate Covalent Inhibitors for the SARS‐CoV‐2 Main Cysteine Protease
- 19 February 2021
- journal article
- research article
- Published by Wiley in Angewandte Chemie
- Vol. 133 (19), 10811-10818
- https://doi.org/10.1002/ange.202016768
Abstract
No abstract availableFunding Information
- National Institute of Allergy and Infectious Diseases (R21 AI138934)
This publication has 53 references indexed in Scilit:
- Gold Metallodrugs to Target Coronavirus Proteins: Inhibitory Effects on the Spike-ACE2 Interaction and on PLpro Protease Activity by Auranofin and Gold OrganometallicsChemistry – A European Journal, 2020
- A Role for Metal-Based Drugs in Fighting COVID-19 Infection? The Case of AuranofinACS Medicinal Chemistry Letters, 2020
- Emerging coronaviruses: Genome structure, replication, and pathogenesisJournal of Medical Virology, 2020
- Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agentsBioorganic & Medicinal Chemistry Letters, 2018
- Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design elementEuropean Journal of Medicinal Chemistry, 2018
- Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modesAntiviral Research, 2018
- Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common MarmosetThe Journal of Infectious Diseases, 2015
- Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Main ProteaseJournal of Medicinal Chemistry, 2006
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004
- Cysteine proteases of positive strand RNA viruses and chymotrypsin‐like serine proteasesFEBS Letters, 1989